These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35068172)

  • 61. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.
    Houssami N; Abraham LA; Kerlikowske K; Buist DS; Irwig L; Lee J; Miglioretti DL
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):946-61. PubMed ID: 23513042
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of the Interaction Between Mammographic Breast Density, Body Mass Index, and Menopausal Status With Breast Cancer Risk Among Korean Women.
    Tran TXM; Moon SG; Kim S; Park B
    JAMA Netw Open; 2021 Dec; 4(12):e2139161. PubMed ID: 34940866
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.
    Holloway CMB; Jiang L; Whitehead M; Racz JM; Groome PA
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1769-1775. PubMed ID: 29909564
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening women aged less than 50 years with a family history of breast cancer.
    Kollias J; Sibbering DM; Blamey RW; Holland PA; Obuszko Z; Wilson AR; Evans AJ; Ellis IO; Elston CW
    Eur J Cancer; 1998 May; 34(6):878-83. PubMed ID: 9797701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario site of the Breast Cancer Family Registry.
    Ritvo P; Edwards SA; Glendon G; Mirea L; Knight JA; Andrulis IL; Chiarelli AM
    BMC Public Health; 2012 Jul; 12():518. PubMed ID: 22788119
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mammographic features and breast cancer risk: effects with time, age, and menopause status.
    Byrne C; Schairer C; Wolfe J; Parekh N; Salane M; Brinton LA; Hoover R; Haile R
    J Natl Cancer Inst; 1995 Nov; 87(21):1622-9. PubMed ID: 7563205
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Harms of Restrictive Risk-Based Mammographic Breast Cancer Screening.
    Neal CH; Rahman WT; Joe AI; Noroozian M; Pinsky RW; Helvie MA
    AJR Am J Roentgenol; 2018 Jan; 210(1):228-234. PubMed ID: 29091007
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old.
    Price ER; Keedy AW; Gidwaney R; Sickles EA; Joe BN
    AJR Am J Roentgenol; 2015 Dec; 205(6):1360-4. PubMed ID: 26204111
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
    Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
    JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer.
    Mittmann N; Seung SJ; Diong C; Gatley JM; Wolfson M; Guertin MH; Pashayan N; Simard J; Chiarelli AM
    Curr Oncol; 2022 Oct; 29(11):8330-8339. PubMed ID: 36354717
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Organized breast screening improves reattendance compared to physician referral: a case control study.
    Makedonov I; Gu S; Paszat LF;
    BMC Cancer; 2015 Apr; 15():315. PubMed ID: 25928416
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Screening outcomes by risk factor and age: evidence from BreastScreen WA for discussions of risk-stratified population screening.
    Noguchi N; Marinovich ML; Wylie EJ; Lund HG; Houssami N
    Med J Aust; 2021 Oct; 215(8):359-365. PubMed ID: 34374095
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.
    Puvanesarajah S; Nyante SJ; Kuzmiak CM; Chen M; Tse CK; Sun X; Allott EH; Kirk EL; Carey LA; Perou CM; Olshan AF; Henderson LM; Troester MA
    Cancer Prev Res (Phila); 2018 Jun; 11(6):327-336. PubMed ID: 29622545
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
    Hofvind S; Skaane P
    Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.